UB Paderborn / Katalog / Suche / in CDI

La France peine à transformer son excellence scientifique en applications concrètes contre le cancer

Bulletin du cancer, 2012-07, Vol.99 (7-8), p.727-728

2012

Volltextzugriff (PDF)

A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenografts

International journal of cancer, 2005-01, Vol.113 (2), p.316-328

2005

Volltextzugriff (PDF)

Determination of risks of lower adherence to CPAP treatment before their first use by patients

Journal of health psychology, 2022-01, Vol.27 (1), p.223-235

2022

Volltextzugriff (PDF)

Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents

Drug discovery today, 2006-04, Vol.11 (7-8), p.283-299

2006

Volltextzugriff (PDF)

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

European journal of pharmacology, 2001-05, Vol.420 (2-3), p.103-112

2001

Volltextzugriff (PDF)

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

BMC health services research, 2014-11, Vol.14 (1), p.537-537, Article 537

2014

Volltextzugriff (PDF)

Efficacy of selective 5‐HT6 receptor ligands determined by monitoring 5‐HT6 receptor‐mediated cAMP signaling pathways

British journal of pharmacology, 2006-08, Vol.148 (8), p.1133-1143

2006

Volltextzugriff (PDF)

Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists

Naunyn-Schmiedeberg's archives of pharmacology, 2006-10, Vol.374 (1), p.31-39

2006

Volltextzugriff (PDF)

Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

Biochemical pharmacology, 2000-12, Vol.60 (12), p.1743-1750

Pauwels, Petrus J

2000

Volltextzugriff (PDF)

Unravelling multiple ligand-activation binding sites using RASSL receptors

Trends in pharmacological sciences (Regular ed.), 2003-10, Vol.24 (10), p.504-507

Pauwels, Petrus J

2003

Volltextzugriff (PDF)

Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells

Journal of pharmacological and toxicological methods, 2007-03, Vol.55 (2), p.144-150

2007

Volltextzugriff (PDF)

Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation

The Journal of pharmacology and experimental therapeutics, 2003-11, Vol.307 (2), p.608

2003

Volltextzugriff (PDF)

7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes: March 20–21, 2012, Lyon, France

mAbs, 2012-07, Vol.4 (4), p.434-444

2012

Volltextzugriff (PDF)

Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors

Journal of medicinal chemistry, 1995-09, Vol.38 (18), p.3602-3607

1995

Volltextzugriff (PDF)

Modulation of ligand responses by coupling of α2A-adrenoceptors to diverse Gα-proteins

Biochemical pharmacology, 2001-05, Vol.61 (9), p.1079-1092

2001

Volltextzugriff (PDF)

Serotonin Dimers: Application of the Bivalent Ligand Approach to the Design of New Potent and Selective 5-HT1B/1D Agonists

Journal of medicinal chemistry, 1996-12, Vol.39 (25), p.4920-4927

1996

Volltextzugriff (PDF)

Different regulation of RGS2 mRNA by haloperidol and clozapine

Neuroreport, 2001-06, Vol.12 (8), p.1731-1735

2001

Volltextzugriff (PDF)

Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht1F receptor

European journal of pharmacology, 2002-02, Vol.436 (1-2), p.23-33

2002

Volltextzugriff (PDF)

Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

Neuroscience letters, 2001-07, Vol.307 (1), p.45-48

2001

Volltextzugriff (PDF)

Molecular cloning, pharmacological properties and tissue distribution of the porcine 5‐HT1B receptor

British journal of pharmacology, 2001-07, Vol.133 (6), p.891-901

2001

Volltextzugriff (PDF)

Differentiation between Partial Agonists and Neutral 5-HT1B Antagonists by Chemical Modulation of 3-[3-(N,N-Dimethylamino)propyl]-4-hydroxy- N-[4-(pyridin-4-yl)phenyl]benzamide (GR-55562)

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3542-3550

1997

Volltextzugriff (PDF)

New Substituted 1-(2,3-Dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl Derivatives with α2-Adrenoceptor Antagonist Activity

Journal of medicinal chemistry, 2000-10, Vol.43 (20), p.3653-3664

2000

Volltextzugriff (PDF)

Partial to complete antagonism by putative antagonists at the wild‐type α 2C ‐adrenoceptor based on kinetic analyses of agonist : antagonist interactions

British journal of pharmacology, 2009-01, Vol.131 (7), p.1385-1390

2009

Volltextzugriff (PDF)

5-HT1B Receptor Antagonist Properties of Novel Arylpiperazide Derivatives of 1-Naphthylpiperazine

Journal of medicinal chemistry, 1997-11, Vol.40 (24), p.3974-3978

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

La France peine à transformer son excellence scientifique en applications concrètes contre le cancer

A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenografts

Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)

Determination of risks of lower adherence to CPAP treatment before their first use by patients

Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

Efficacy of selective 5‐HT6 receptor ligands determined by monitoring 5‐HT6 receptor‐mediated cAMP signaling pathways

Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists

Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

Unravelling multiple ligand-activation binding sites using RASSL receptors

Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells

Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation

7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes: March 20–21, 2012, Lyon, France

Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors

Modulation of ligand responses by coupling of α2A-adrenoceptors to diverse Gα-proteins

Serotonin Dimers: Application of the Bivalent Ligand Approach to the Design of New Potent and Selective 5-HT1B/1D Agonists

Different regulation of RGS2 mRNA by haloperidol and clozapine

Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht1F receptor

Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

Molecular cloning, pharmacological properties and tissue distribution of the porcine 5‐HT1B receptor

Differentiation between Partial Agonists and Neutral 5-HT1B Antagonists by Chemical Modulation of 3-[3-(N,N-Dimethylamino)propyl]-4-hydroxy- N-[4-(pyridin-4-yl)phenyl]benzamide (GR-55562)

New Substituted 1-(2,3-Dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl Derivatives with α2-Adrenoceptor Antagonist Activity

Partial to complete antagonism by putative antagonists at the wild‐type α 2C ‐adrenoceptor based on kinetic analyses of agonist : antagonist interactions

5-HT1B Receptor Antagonist Properties of Novel Arylpiperazide Derivatives of 1-Naphthylpiperazine

Suchergebnisse filtern